N-[3-(2-hydroxy-3-phosphorosooxypropoxy)propyl]-6-oxo-6-[3-[2-[2-[2-[4-(sulfanylmethyl)phenoxy]ethoxy]ethoxy]ethyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-13-yl]hexanamide

C40H50N5O9PS — CID 166730027

IUPACN-[3-(2-hydroxy-3-phosphorosooxypropoxy)propyl]-6-oxo-6-[3-[2-[2-[2-[4-(sulfanylmethyl)phenoxy]ethoxy]ethoxy]ethyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-13-yl]hexanamide
SMILESO=POCC(O)COCCCNC(=O)CCCCC(=O)N1Cc2ccccc2-c2c(nnn2CCOCCOCCOc2ccc(CS)cc2)-c2ccccc21
InChIInChI=1S/C40H50N5O9PS/c46-32(28-54-55-49)27-52-20-7-18-41-37(47)12-5-6-13-38(48)44-26-31-8-1-2-9-34(31)40-39(35-10-3-4-11-36(35)44)42-43-45(40)19-21-50-22-23-51-24-25-53-33-16-14-30(29-56)15-17-33/h1-4,8-11,14-17,32,46,56H,5-7,12-13,18-29H2,(H,41,47)
InChIKeyFRGDWZWWYYNFKF-UHFFFAOYSA-N
MW807.91 g/mol
LogP5.67
Rot. Bonds25

About N-[3-(2-hydroxy-3-phosphorosooxypropoxy)propyl]-6-oxo-6-[3-[2-[2-[2-[4-(sulfanylmethyl)phenoxy]ethoxy]ethoxy]ethyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-13-yl]hexanamide

N-[3-(2-hydroxy-3-phosphorosooxypropoxy)propyl]-6-oxo-6-[3-[2-[2-[2-[4-(sulfanylmethyl)phenoxy]ethoxy]ethoxy]ethyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-13-yl]hexanamide (PubChem CID 166730027) has the molecular formula C40H50N5O9PS and a molecular weight of 807.91 g/mol. Its IUPAC name is N-[3-(2-hydroxy-3-phosphorosooxypropoxy)propyl]-6-oxo-6-[3-[2-[2-[2-[4-(sulfanylmethyl)phenoxy]ethoxy]ethoxy]ethyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-13-yl]hexanamide.

Molecular Properties

Compound NameN-[3-(2-hydroxy-3-phosphorosooxypropoxy)propyl]-6-oxo-6-[3-[2-[2-[2-[4-(sulfanylmethyl)phenoxy]ethoxy]ethoxy]ethyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-13-yl]hexanamide
PubChem CID166730027
Molecular FormulaC40H50N5O9PS
Molecular Weight807.91 g/mol
Exact Mass807.31
IUPAC NameN-[3-(2-hydroxy-3-phosphorosooxypropoxy)propyl]-6-oxo-6-[3-[2-[2-[2-[4-(sulfanylmethyl)phenoxy]ethoxy]ethoxy]ethyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-13-yl]hexanamide
SMILESO=POCC(O)COCCCNC(=O)CCCCC(=O)N1Cc2ccccc2-c2c(nnn2CCOCCOCCOc2ccc(CS)cc2)-c2ccccc21
InChIInChI=1S/C40H50N5O9PS/c46-32(28-54-55-49)27-52-20-7-18-41-37(47)12-5-6-13-38(48)44-26-31-8-1-2-9-34(31)40-39(35-10-3-4-11-36(35)44)42-43-45(40)19-21-50-22-23-51-24-25-53-33-16-14-30(29-56)15-17-33/h1-4,8-11,14-17,32,46,56H,5-7,12-13,18-29H2,(H,41,47)
InChIKeyFRGDWZWWYYNFKF-UHFFFAOYSA-N
XLogP5.67
TPSA163.57 Ų
H-Bond Donors3
H-Bond Acceptors13
Rotatable Bonds25
Heavy Atoms56
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500807.91
LogP ≤ 55.67
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}, {'alert_name': 'thiol_2', 'substructure': 'N/A'}

Analyze N-[3-(2-hydroxy-3-phosphorosooxypropoxy)propyl]-6-oxo-6-[3-[2-[2-[2-[4-(sulfanylmethyl)phenoxy]ethoxy]ethoxy]ethyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-13-yl]hexanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[3-(2-hydroxy-3-phosphorosooxypropoxy)propyl]-6-oxo-6-[3-[2-[2-[2-[4-(sulfanylmethyl)phenoxy]ethoxy]ethoxy]ethyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-13-yl]hexanamide?
The IUPAC name of N-[3-(2-hydroxy-3-phosphorosooxypropoxy)propyl]-6-oxo-6-[3-[2-[2-[2-[4-(sulfanylmethyl)phenoxy]ethoxy]ethoxy]ethyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-13-yl]hexanamide (CID 166730027) is N-[3-(2-hydroxy-3-phosphorosooxypropoxy)propyl]-6-oxo-6-[3-[2-[2-[2-[4-(sulfanylmethyl)phenoxy]ethoxy]ethoxy]ethyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-13-yl]hexanamide.
What is the SMILES notation for N-[3-(2-hydroxy-3-phosphorosooxypropoxy)propyl]-6-oxo-6-[3-[2-[2-[2-[4-(sulfanylmethyl)phenoxy]ethoxy]ethoxy]ethyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-13-yl]hexanamide?
The canonical SMILES for N-[3-(2-hydroxy-3-phosphorosooxypropoxy)propyl]-6-oxo-6-[3-[2-[2-[2-[4-(sulfanylmethyl)phenoxy]ethoxy]ethoxy]ethyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-13-yl]hexanamide is O=POCC(O)COCCCNC(=O)CCCCC(=O)N1Cc2ccccc2-c2c(nnn2CCOCCOCCOc2ccc(CS)cc2)-c2ccccc21.
What is the InChIKey of N-[3-(2-hydroxy-3-phosphorosooxypropoxy)propyl]-6-oxo-6-[3-[2-[2-[2-[4-(sulfanylmethyl)phenoxy]ethoxy]ethoxy]ethyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-13-yl]hexanamide?
The InChIKey is FRGDWZWWYYNFKF-UHFFFAOYSA-N. The full InChI is InChI=1S/C40H50N5O9PS/c46-32(28-54-55-49)27-52-20-7-18-41-37(47)12-5-6-13-38(48)44-26-31-8-1-2-9-34(31)40-39(35-10-3-4-11-36(35)44)42-43-45(40)19-21-50-22-23-51-24-25-53-33-16-14-30(29-56)15-17-33/h1-4,8-11,14-17,32,46,56H,5-7,12-13,18-29H2,(H,41,47).
What are the key properties of N-[3-(2-hydroxy-3-phosphorosooxypropoxy)propyl]-6-oxo-6-[3-[2-[2-[2-[4-(sulfanylmethyl)phenoxy]ethoxy]ethoxy]ethyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-13-yl]hexanamide?
N-[3-(2-hydroxy-3-phosphorosooxypropoxy)propyl]-6-oxo-6-[3-[2-[2-[2-[4-(sulfanylmethyl)phenoxy]ethoxy]ethoxy]ethyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-13-yl]hexanamide has a molecular weight of 807.91 g/mol, XLogP of 5.67, 25 rotatable bonds, 3 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-(2-hydroxy-3-phosphorosooxypropoxy)propyl]-6-oxo-6-[3-[2-[2-[2-[4-(sulfanylmethyl)phenoxy]ethoxy]ethoxy]ethyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),4,7,9,11,15,17-octaen-13-yl]hexanamide is sourced from PubChem (CID 166730027), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).